Market Capitalization of Orchid Pharma Ltd
Orchid Pharma Ltd
NSE: ORCHPHARMA
Market Cap
Key Highlights
- The Market Cap of Orchid Pharma Ltd is ₹ 3498 crore as of 23 Jan 26 .
- The Latest Trading Price of Orchid Pharma Ltd is ₹ 689.8 as of 23 Jan 15:30 .
Orchid Pharma Ltd
NSE: ORCHPHARMA
Share Price
Market Price of Orchid Pharma Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 23 Jan 2026 | 689.8 |
| 22 Jan 2026 | 706.75 |
| 21 Jan 2026 | 697.6 |
| 20 Jan 2026 | 697.45 |
| 19 Jan 2026 | 710.2 |
| 16 Jan 2026 | 723.4 |
| 14 Jan 2026 | 740.25 |
| 13 Jan 2026 | 733.55 |
| 12 Jan 2026 | 722.65 |
| 09 Jan 2026 | 729.6 |
SWOT Analysis Of Orchid Pharma Ltd
BlinkX Score for Orchid Pharma Ltd
Asset Value vs Market Value of Orchid Pharma Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Orchid Pharma Ltd
Historical P/E Ratio of Orchid Pharma Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Orchid Pharma Ltd
Historical Revenue of Orchid Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Orchid Pharma Ltd
Historical EBITDA of Orchid Pharma Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Orchid Pharma Ltd
Historical Net Profit of Orchid Pharma Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Orchid Pharma Ltd
Dividend Payout Over Time
About Orchid Pharma Ltd
- Orchid Pharma Limited, is a vertically integrated pharmaceutical company with established research, manufacturing and marketing capabilities across multi-therapeutic domains.
- Orchid's world class manufacturing infrastructure include USFDA compliant API and Finished Dosage Form facilities at Chennai in India.
- The Company has dedicated state-of-art and GLP compliant R&D infrastructure for Process Research, Drug Discovery and Pharmaceutical Research at Chennai. The Company has a portfolio of antibiotics, and veterinary products.
- Antibiotics are life-saving drugs used to ght infections.
- Different classes of antibiotics include Beta-lactam, Macrolide, Fluoroquinolone, Imidazoleetc.
Orchid Pharma Ltd News Hub
Orchid Pharma consolidated net profit rises 212.23% in the June 2024 quarter
Net profit of Orchid Pharma rose 212.23% to Rs 29.35 crore in the quarter ended June 2024 as against
Read more
13 Aug 24
Orchid Pharma announces board meeting date
Orchid Pharma will hold a meeting of the Board of Directors of the Company on 12 August 2024. Powere
Read more
10 Aug 24
Orchid Pharma to hold board meeting
Orchid Pharma will hold a meeting of the Board of Directors of the Company on 11 November 2024 Power
Read more
06 Nov 24
Orchid Pharma consolidated net profit rises 37.58% in the September 2024 quarter
Net profit of Orchid Pharma rose 37.58% to Rs 27.24 crore in the quarter ended September 2024 as aga
Read more
11 Nov 24
